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ABSTRACT There is limited knowledge on the incidence, diagnostic yield, and cost
associated with inappropriate repeat urine cultures. The factors that affect repeat
urine culturing practices are not well understood. We conducted a retrospective
study of adult inpatients who had ⱖ1 urine culture performed during their hospitalization between January 2015 and February 2018. We analyzed the proportion of inappropriate repeat urine cultures performed ⬍48 h after the index culture. We deﬁned an inappropriate repeat urine culture to be a repeat urine culture performed
following a negative index culture or a repeat urine specimen obtained from the
same urinary catheter. Overall, 28,141 urine cultures were performed on 21,306 patients. There were 2,060 (7.3%) urine cultures repeated in ⬍48 h. Of these, 1,120
(54.4%) urine cultures were inappropriate. Predictors for inappropriate repeat urine
cultures included collection of the initial urine sample for culture in the emergency
department (adjusted odds ratio [aOR], 5.65; 95% conﬁdence interval [CI], 4.70 to
6.78), male gender (aOR, 1.61; 95% CI, 1.42 to 1.84), congestive heart failure (aOR,
1.20; 95% CI, 1.03 to 1.38), and a longer hospital stay (aOR, 1.01 per day; 95% CI,
1.00 to 1.01). A patient with an index urine culture obtained from an indwelling
catheter (aOR, 0.65; 95% CI, 0.53 to 0.80) was less likely to have an inappropriate repeat culture. Among 1,120 negative index urine cultures, only 4.7% of repeat cultures were positive for bacteriuria. The estimated laboratory charges for inappropriate repeat urine cultures were $16,800 over the study period. Among inpatients,
over half of all urine cultures repeated in ⬍48 h were inappropriate. This offers an
opportunity for diagnostic stewardship and optimization of antimicrobial use.
KEYWORDS diagnostic stewardship, diagnostic yield, inappropriate testing,

urine culture

I

n recent decades, the overutilization of laboratory testing has been recognized as a
prevalent issue in health care. Inappropriate duplicative testing is an important subset of
diagnostic test overuse (1). Although duplicative laboratory testing is indicated in some
instances, it is often unnecessary and provides limited clinically important information,
especially if the laboratory test is repeated in an inappropriately short interval (2, 3).
Urine cultures are among the most frequently performed tests in clinical microbiology laboratories (4). An accurate diagnosis of urinary tract infection is important to
identify patients who will beneﬁt from appropriate antimicrobial treatment. However,
unnecessary urine culture testing can result in increased health care costs and inappropriate antimicrobial treatment for asymptomatic bacteriuria, which impedes antimicrobial stewardship efforts and can lead to downstream antimicrobial resistance and
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Clostridioides difﬁcile infection (5). Utilization practices, the diagnostic yield of repeat
urine culture among hospitalized patients, and the factors that affect ordering practices
are not well understood.
The purpose of our study was to evaluate the incidence, predictors, diagnostic yield,
and economic burden of inappropriate repeat urine cultures performed less than 48 h
after the index culture among hospitalized patients. These results have the potential to
improve diagnostic test utilization, thereby reducing health care costs and minimizing
inappropriate antimicrobial therapy.
MATERIALS AND METHODS
Setting. This was a retrospective study conducted at Barnes-Jewish Hospital, a 1,250-bed teaching
hospital, from January 2015 to February 2018. We included all hospitalized patients aged ⱖ18 years who
had at least one urine sample processed by culture during their hospital stay or within 24 h prior to
admission.
Deﬁnitions. For the purpose of this study, we deﬁned the ﬁrst urine culture performed during
admission or within 24 h prior to admission to be the “initial” culture. A sample for an initial urine culture
could be obtained in an outpatient setting (e.g., a clinic, skilled nursing facility, or long-term acute care
facility), the emergency department, or an inpatient setting. We deﬁned an “index” urine culture to be
the ﬁrst urine culture performed prior to a repeat urine culture(s). For some of the hospitalized patients,
the index urine cultures were also the initial urine cultures.
Based on previous literature (2, 6), we deﬁned a repeat urine culture performed within less than 48 h to
be inappropriate if either (i) a repeat urine culture was performed following a negative index culture or (ii) a
repeat urine specimen was obtained from the same indwelling urinary catheter. We considered a repeat urine
culture to be clinically appropriate if (i) it was repeated for the conﬁrmation of a positive index culture or (ii)
a specimen for a repeat catheterized urine culture was obtained from a newly inserted indwelling urinary
catheter, given concerns of initial culture contamination from an old urinary catheter (2, 6).
Pertinent data on the patients’ demographics, comorbidities, urine cultures (date of collection, type
of urine specimen, culture result, ordering service, ordering physician), results of an urinalysis associated
with the urine cultures (i.e., results of an urinalysis performed either concomitantly with or within 1 h
before the index urine culture), and disposition were extracted from the medical informatics database.
The type of urine specimen was classiﬁed into clean-catch/straight catheterized, indwelling catheterized
(e.g., the specimen was obtained from a Foley or suprapubic catheter), or procedural (e.g., the specimen
was obtained by suprapubic aspiration, percutaneous nephrostomy tube placement, or cystoscopy), as
indicated by the ordering physician. Due to the low numbers of straight catheterized urine cultures (0.3%
of all urine cultures), these were grouped together with clean-catch urine cultures. A positive urine
culture for all specimen types was deﬁned on the basis of the established clinical breakpoints, as
previously published (7, 8). We deﬁned a negative urine culture as having insigniﬁcant growth below a
threshold or no growth. A urine culture was considered contaminated if there were ⱖ3 different species
of organisms with colony counts recovered above a threshold. An abnormal urinalysis was deﬁned as a
leukocyte esterase value of ⱖ1 on urine dipstick and ⬎5 white blood cells per high-power ﬁeld on urine
microscopy (9).
The primary study outcome was the proportion of inappropriate repeat urine cultures performed
within less than 48 h following the index urine culture among inpatients. The secondary outcomes were
the diagnostic yield of inappropriate repeat urine cultures in detecting bacteriuria, predictors, and direct
laboratory charges associated with inappropriate repeat urine cultures performed within less than 48 h.
The gross charges estimation for a urine culture test was calculated on the basis of the Medicare Clinical
Laboratory Fee Schedule, using a national median Medicare payment rate of $15.00 per urine culture (not
adjusted to inﬂation) (10).
Statistical analyses. The unit of analysis in our study was reported on a per admission basis. Baseline
characteristics and urine culture data were compared on the basis of inappropriate repeat urine culturing
status using the chi-square test, the Fisher exact test, or univariable logistic regression for categorical
variables and the Kruskal-Wallis test for continuous variables. To determine the independent predictors
associated with inappropriate repeat urine cultures performed within less than 48 h, we performed
multivariable logistic regression analysis. All variables with a P value of ⬍0.20 in univariable analysis were
considered for entry into the model using forward stepwise regression, with the variable being retained
in the ﬁnal model if the P value was ⬍0.05. The remaining patients in the study without inappropriate
repeat urine cultures during their admission (i.e., patients with only one urine culture or patients with an
appropriate repeat urine culture) were regarded as the reference group (controls). We also evaluated the
effect of urine culture specimen type (index versus initial) and location among the independent
predictors of inappropriate repeat urine cultures. For this, random selection of either the index culture
or the initial culture for the control group was performed to avoid a selection bias of oversampling of
urine cultures performed with specimens collected in the emergency department.
We performed a sensitivity analysis to determine if our results varied on the basis of inappropriate
criteria for repeat urine cultures. For this analysis, we considered all repeat urine cultures performed
within less than 48 h after the index culture to be inappropriate. Data were analyzed using SAS (version
9.3) software (SAS Institute Inc., Cary, NC). This study was approved by the Human Research Protection
Ofﬁce at Washington University in St. Louis, MO, with a waiver of consent.
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RESULTS
A total of 28,141 urine cultures were performed among 21,306 hospitalized patients
during the study period. There were 23,224 clean-catch specimens, 97 straight catheterized specimens, 4,567 indwelling catheter specimens, and 253 procedural specimens. Of these, 4,678 (22.0%) patients had more than one urine culture performed,
accounting for 11,513 of all urine cultures (4,678 index cultures, 6,835 repeat urine
cultures). Among the 4,678 patients with repeat urine cultures, 1,868 (39.9%) had
repeat urine cultures performed within 48 h following the index culture. We identiﬁed
that 1,120 (54.4%) of 2,060 urine cultures were inappropriately repeated within 48 h
following the index urine culture. Of all inappropriate repeat testing, the proportion
was the highest for patients who had clean-catch index urine cultures (94.5%) and who
were admitted to intensive care units (ICUs) (40.2%). Only 53 (4.7%) of 1,120 inappropriate repeat urine cultures performed within less than 48 h had a positive urine culture.
Of these, 41.5% were positive for Enterobacteriaceae, 18.9% were positive for enterococci, and 17.0% were positive for Candida spp.
Baseline demographics were relatively similar between the control group and the
groups with inappropriate repeat urine cultures (Table 1). In univariable analysis,
patients with inappropriate repeat urine culture testing were more likely to be male
(59.1% versus 47.1%, P ⬍ 0.001), have a sample for the index urine culture obtained in
the emergency department or other outpatient settings (16.8% versus 3.6%, P ⬍ 0.001),
and have a longer median length of hospital stay (9 versus 7 days, P ⬍ 0.001). Index
urine cultures were less likely to be of an indwelling catheterized specimen in the
inappropriate repeat testing group (10.3% versus 13.6%, P ⫽ 0.002). There was no
difference in the proportion of urinalyses performed in association with the index
cultures between the two study groups. The majority of the inappropriate repeat urine
cultures were ordered by the same clinical service that ordered the index culture,
ranging from 61.5% to 96.1% (Table 2). Notably, 29% (n ⫽ 325 out of 1,120) of
inappropriate repeat urine cultures were ordered by the same physician.
Among inpatients who had at least one urine culture, the independent predictors
associated with having an inappropriate repeat urine culture performed within 48 h of
the index culture included an initial urine culture performed with a specimen collected
in the emergency department (adjusted odds ratio [aOR], 5.65; 95% conﬁdence interval
[CI], 4.70 to 6.78), male gender (aOR, 1.61; 95% CI, 1.42 to 1.84), congestive heart failure
(aOR, 1.20; 95% CI, 1.03 to 1.38), and a longer hospital stay (aOR, 1.01 per day; 95% CI,
1.00 to 1.01 per day). An index indwelling catheterized urine culture (aOR, 0.65; 95% CI,
0.53 to 0.80) was less likely to be associated with inappropriate repeat testing. In our
sensitivity analysis, there were no signiﬁcant changes in our univariable and multivariable results when we compared all inpatients who had repeat urine cultures performed
within less than 48 h, irrespective of their clinical appropriateness criteria (data not
shown). The estimated laboratory charges for these inappropriate repeat urine cultures
were $16,800 during the 38-month study period.
DISCUSSION
In this retrospective study, we found that, for 7.3% of all inpatient urine cultures,
repeat testing was performed within 48 h following an index culture and that 54.4% of
these repeated urine cultures were inappropriate, based on previously published
criteria. Among inpatients with a negative index urine culture, the diagnostic gain of an
inappropriate urine culture repeated within 48 h for detecting bacteriuria was only
4.7%. Several other studies have examined the utility of repeat microbiological cultures
among inpatients. However, these studies were performed in the late 1990s, and the
landscape of diagnostic test utilization and antimicrobial resistance has changed
considerably since that time. A study by Bates et al. found that 26% of the repeat urine,
sputum, and stool cultures performed within 36 h were redundant (2). Onderdonk et al.
reported that 14.6% of the repeated urine cultures were unnecessary, based on
predeﬁned testing frequency criteria (e.g., no more than one urine culture per day) (11).
Nevertheless, the proportion of inappropriate inpatient urine cultures repeated in less
October 2019 Volume 57 Issue 10 e00910-19

jcm.asm.org 3

Foong et al.

Journal of Clinical Microbiology

TABLE 1 Characteristics and comparison of risk factors for inappropriate repeat urine culture performed within 48 h following the index
urine culture among 21,306 inpatients with ⬎1 urine culturej
Value for the following patients:

Multivariable analysis
Remaining
patientsa
(n ⴝ 20,266)
9,540 (47.1)
62 (49–72)
7 (4–16)

No. (%) of patients by race
White
Othersb

14,649 (68.8)
6,657 (31.2)

729 (70.1)
311 (29.9)

13,920 (68.7)
6,346 (31.3)

No. (%) of patients with the following
comorbidities:
CHF
Chronic lung disease
ESRD
Cirrhosis
Malignancy
HIV infection
Genitourinary procedure

5,609 (26.3)
4,762 (22.4)
897 (4.2)
862 (4.0)
3,544 (16.6)
67 (0.3)
253 (1.2)

305 (29.3)
213 (20.5)
54 (5.2)
39 (3.8)
169 (16.3)
4 (0.4)
9 (0.9)

5,304 (26.2)
4,549 (22.4)
843 (4.2)
823 (4.1)
3,375 (16.7)
63 (0.3)
244 (1.2)

No. (%) of patients with an initial urine
culture by specimen type
Clean catch/straight catheterized
Indwelling catheterized
Proceduralc

18,252 (85.7)
2,857 (13.4)
197 (0.9)

933 (89.7)
107 (10.3)

No. (%) of patients with an initial urine
culture by locationd
ED and other outpatient facilitye
Inpatient

907 (4.3)
20,399 (95.7)

No. (%) of patients with an urinalysisf
No. (%) of patients with an abnormal
urinalysisg
No. (%) of patients with the following
discharge statush:
Discharged to home
Discharged to facility
Othersi

P value
⬍0.001
0.175
⬍0.001

aOR (95% CI)
1.61 (1.42–1.84)
1.00 (0.99–1.00)
1.01 (1.00–1.01)

P value
⬍0.001
0.088
⬍0.001

0.024
0.138
0.106
0.620
0.733
0.569
0.326

1.20 (1.03–1.38)

0.018

17,319 (85.4)
2,750 (13.6)
197 (1.0)

Reference
0.002

Reference
0.65 (0.53–0.80)

⬍0.001

175 (16.8)
865 (83.2)

732 (3.6)
19,534 (96.4)

⬍0.001

5.65 (4.70–6.78)

⬍0.001

6,738 (31.6)
3,915 (18.4)

310 (29.8)
170 (16.3)

6,428 (31.7)
3,745 (18.5)

0.196
0.080

13,860 (65.5)
5,419 (25.6)
1,879 (8.9)

606 (58.9)
284 (27.6)
139 (13.5)

13,254 (65.9)
5,135 (25.5)
1,740 (8.6)

Reference
0.010
⬍0.001

Reference
1.10 (0.94–1.28)
1.60 (1.31–1.95)

0.086
⬍0.001

0.339

aIncludes

inpatients who had single urine cultures or appropriate repeated urine cultures.
includes black (all patients ⫽ 5,447, patients with an inappropriate repeat urine culture ⫽ 251, remaining patients ⫽ 5,196) and other races (all patients ⫽
1,210, patients with an inappropriate repeat urine culture ⫽ 60, remaining patients ⫽ 1,150).
cThis included specimen collection by suprapubic aspiration, percutaneous nephrostomy tube placement, and cystoscopy.
dIn the inappropriate repeat urine culture arm, 75% of the initial cultures were index cultures, while 25% were not.
eOutpatient facility (total ⫽ 82) included a clinic, skilled nursing facility, and long-term acute care facility.
fUrinalysis was performed either concomitantly with or within 1 h before the index urine culture.
gAn abnormal urinalysis was deﬁned as a leukocyte esterase value of ⱖ1 on urine dipstick and ⬎5 white blood cells per high-power ﬁeld on urine microscopy.
hThere were 148 missing data.
iThis included leaving against medical advice and death.
jAbbreviations: aOR, adjusted odd ratio; CI, conﬁdence interval; IQR, interquartile range; CHF, congestive heart failure; ESRD, end-stage renal disease; HIV, human
immunodeﬁciency virus; ED, emergency department.
bThis

than 48 h remained unclear, and the diagnostic yield of inappropriate repeat urine
cultures was also not described in these two studies (2, 11).
The diagnostic gain from repeat clinical microbiology testing that is performed
within a very short time frame is very limited (2, 3). Despite several clinical practice
guidelines with recommendations for improving urine culturing practice (6, 12, 13),
physician testing practices still vary (1, 2, 5, 11). Previous studies suggested potential
factors contributing to unnecessary repeat testing, including an unawareness of preexisting orders and a failure to determine when the last test was performed or to check
October 2019 Volume 57 Issue 10 e00910-19
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Characteristic
No. (%) of male patients
Median (IQR) age (yr)
Median (IQR) length of stay (days)

All inpatients
(n ⴝ 21,306)
10,155 (47.7)
62 (49–72)
7 (4–16)

Inpatients with >1
inappropriate repeat
urine culture in
<48 h (n ⴝ 1,040)
615 (59.1)
61 (49–71)
9 (4–20)

0
190 (90.9)
8 (2.2)
0
0
0
1 (3.9)
0
0
0

116 (87.2)
0
9 (2.5)
0
0
2 (5.2)
0
0
0
2 (15.4)

16 (12.0)
17 (8.1)
332 (93.0)
12 (9.5)
10 (20.8)
11 (29.0)
0
1 (16.7)
0
3 (23.1)

ICU
48 (31.8)
1 (0.8)
1 (0.5)
0
115 (90.5)
0
0
0
0
1 (8.3)
0

SCT/oncology
16 (10.6)
0
0
3 (0.9)
0
38 (79.2)
0
0
0
0
0

Cardiology
5 (3.3)
0
0
5 (1.4)
0
0
25 (65.8)
0
0
0
0

Neurology/
neurosurgery
3 (2.0)

bThe

ICU, intensive care unit; SCT, stem cell transplant.
shaded data are for samples for which repeat urine cultures were ordered by the same clinical service that ordered the index culture.
cOutpatient facilities included a clinic, skilled nursing facility, and long-term acute care facility.
dIncluded are observation and inpatient psychiatric units.

Surgery
30 (19.8)

General
medicine
47 (31.1)
0
1 (0.5)
0
0
0
0
25 (96.1)
0
0
0

Gynecological
oncology
1 (0.7)
0
0
0
0
0
0
0
5 (83.3)
0
0

Obstetrics
0
0
0
0
0
0
0
0
0
11 (91.7)
0

Orthopedics
1 (0.7)

Downloaded from http://jcm.asm.org/ on October 4, 2019 at Washington University in St. Louis
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aAbbreviations:

Ordering service
Emergency department and other
outpatient facilitiesc (n ⫽ 151)
General medicine (n ⫽ 133)
Surgery (n ⫽ 209)
ICU (n ⫽ 357)
SCT/oncology (n ⫽ 127)
Cardiology (n ⫽ 48)
Neurology/neurosurgery (n ⫽ 38)
Gynecologic oncology (n ⫽ 26)
Obstetrics (n ⫽ 6)
Orthopedics (n ⫽ 12)
Other inpatient locationsd (n ⫽ 13)

No. (%) of samples with inappropriate repeat urine culture by ordering serviceb

TABLE 2 Comparison of 1,120 pairs of index and inappropriate repeat urine cultures by ordering servicea

0
0
0
0
0
0
0
0
0
8 (61.5)

Other inpatient
locationsb
0
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pending results (2, 3, 14, 15). In our current study, there was no signiﬁcant difference
in the proportion of associated urinalysis orders between the inappropriate repeat
urine culture and the cultures for the control groups, suggesting a lack of awareness of
the index culture results rather than the urinalysis results as the driving force for
inappropriate repeat urine culturing practice. These factors could potentially explain
our ﬁnding that most inappropriate repeat urine cultures were ordered by the same
clinical service and that up to one-third were ordered by the same physician who
ordered the index culture. ICUs had the highest number of inappropriate repeat urine
cultures. We previously reported that isolated urine cultures, deﬁned as urine cultures
performed without additional diagnostic testing, such as urinalysis or urine microscopy,
were more likely to be ordered among ICU patients (7). Interventions targeted to ICUs
and physicians with outlying ordering behavior may therefore have a great impact on
reducing inappropriate repeat testing.
Among the independent risk factors in our multivariable analysis, a more than 5-fold
increased risk for having inappropriate inpatient repeat urine cultures performed within
48 h following the index culture was found when the initial urine culture was performed with a sample obtained in the emergency department. Other investigators have
found similar ﬁndings for cardiac enzyme testing and suggested that unnecessary
duplicative orders occurred more frequently when patients were transferred from the
emergency department to inpatient units (16). The role of computerized physician order
entry (CPOE) systems in altering physician ordering practices to reduce unnecessary laboratory testing has been well described (3, 8, 17). A computerized pop-up alert screen with
pending results and the most recent completed test result with the date has resulted in a
signiﬁcant reduction in duplicate orders for ordering of panels of tests for acute hepatitis
(17). A similar intervention to indicate to physicians that a recent urine culture was ordered,
is pending, or has been completed, along with the time and date, may lead to more
discerning utilization practices. A thoughtful design of CPOE systems coupled with the
implementation of diagnostic stewardship may play an important role in improving the
cost-effectiveness and quality of clinical patient care (18–20).
In this study, patients who had an index culture of a sample from an indwelling
catheter had a lower risk of having an inappropriate repeat urine culture than those
who had an index culture of clean-catch/straight catheterized and procedural specimens. This ﬁnding could potentially be explained by our institutional intervention of
modifying urine testing order sets in the CPOE system, which was implemented in April
2016 (8). Urinalysis parameters of proteinuria and blood in the urine were excluded
from reﬂex urine culture testing, with the exception of testing for neutropenic patients
(8). This CPOE system-based intervention resulted in a signiﬁcant reduction in the
number of indwelling catheterized urine cultures (75.6%) being performed compared
to the number of clean-catch urine cultures being performed (37.8%) (8). In our study,
we assigned the indwelling catheterized urine cultures to preintervention (January
2015 to April 2016) and postintervention (May 2016 to February 2018) periods, based
on our prior institutional intervention (8). We found that the proportion of all indwelling
catheterized urine cultures was signiﬁcantly lower during the postintervention period
(3,217/16,308 [19.7%] versus 1,035/11,833 [8.7%]; P ⬍ 0.001). A similar ﬁnding was
observed in the proportion of inappropriate repeat indwelling catheterized urine
cultures in our cohort (219/760 [28.8%] versus 48/360 [13.3%]; P ⬍ 0.001).
A limitation of our study is that it is a retrospective study performed at a single,
academic hospital, which limits the generalizability of our results to other settings. We
did not include the data on antimicrobial use. The absence of chart review precluded
the evaluation of test indication, provider characteristic (e.g., level of training), and
longitudinal provider ordering behavior. To offset the lack of test indication by chart
review, we used a relatively conservative deﬁnition for what constitutes an inappropriate repeat urine culture to avoid overestimating its prevalence. We also performed
a sensitivity analysis and compared all inpatients who had repeat urine cultures
performed within less than 48 h, irrespective of their clinical appropriateness criteria,
and found similar results (data not shown). Although we used the Medicare Clinical
jcm.asm.org 6
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Laboratory Fee Schedule as a standardized method of reimbursement for urine culture,
this may not reﬂect the actual laboratory costs, which may vary across hospitals. We
were unable to assess the clinical consequences of reducing the number of inappropriate repeat urine cultures. However, previous studies postulated that elimination of
unnecessary duplicative testing is unlikely to result in clinically signiﬁcant adverse
outcomes (2, 3, 11). The strengths of our study included a large sample size, a
comparison of ordering services, an assessment of the transition of care from emergency department to inpatient services, and a measure of the potential ﬁnancial impact
of duplicate testing on laboratories.
In conclusion, we found in a large academic medical center that over half of urine
cultures repeated on inpatients within 48 h were inappropriate. Notably, the diagnostic
gain of an inappropriate repeat urine culture performed within 48 h for detecting
bacteriuria was less than 5%. Further study is needed to evaluate provider-related
ordering behavior on urine culturing practice and the effect of repeat urine culture
testing on antimicrobial usage and clinical outcomes. Our ﬁndings highlight opportunities for further optimization of CPOE systems for improving diagnostic and antimicrobial stewardship and patient care.

